Send the following on WhatsApp
Continue to Chathttps://it.marketscreener.com/quotazioni/azione/KARO-PHARMA-AB-PUBL-23488759/attualita/Karo-Healthcare-AB-ha-acquisito-i-diritti-del-marchio-OTC-Proctosedyl-da-Bayer-Aktiengesellschaft-X-46141869/?utm_source=whatsapp&utm_medium=social&utm_campaign=share